In € millions, except earnings per share and dividend (in €)

2013 2014 2015

 

2016

2017

Order intake

12,928 14,363 18,880 16,514 14,920

Order book at end of period

24,469 27,885 32,292 33,530 31,914
Sales
12,698
12,974
14,063
14,885
15,795
Total change + 0.3% + 2.2% + 8.4% + 5.8% + 6.1%
Organic change + 3.3% - 1.2% + 4.5% + 6.8% + 7.2%
EBIT (2)
1,011
985
1,216
1,354
1,543
In % of sales 8.0% 7.6% 8.6% 9.1% 9.8%
Adjusted net income , Group share (2)
642
562
809
897
982
Consolidated net income, Group share
573 714 765 946 822
Adjusted net income Group share, per share (EPS)(2)

3.20

2.75

3.89

4.25

4.64
Dividend per share
1.12 1.12 1.36 1.60 1.75(2)
Free operating cash-flow (2)
477
501
1,110
954
1,365
Net cash position at end of period
1,077 1,006 1,978 2,366 2,971
 
Self-funded R&D(4)
638 675 707
743
813
 
Consolidated headcount at year-end
59,467 61,709 62,194 64,071 64,860
 (1) Non-strictly accounting measures. See definitions in the corresponding reference documents.
(2) Proposed to the 23 May 2018 AGM
(3) Including capitalized R&D
Contact
Investor Relations
+33 (0) 1 57 77 89 02